PlasmaTech Biopharmaceuticals, Inc (PTBIW) is a clinical-stage biotechnology company that develops and commercializes novel therapies for serious and life-threatening rare diseases. The company's pipeline includes gene therapy, cell therapy, and regenerative medicine products, targeting diseases such as diabetic foot ulcers, hemophilia, and lung cancer.
As of the market close on February 25, 2023, the current market capitalization for PTBIW is not available as the company is no longer listed on any major stock exchanges.
Please note that PTBIW is a delisted stock and caution should be exercised when considering investing in such securities. Investing in delisted stocks carries higher risks and may result in total loss of investment. It is important to conduct thorough research and consult with a financial advisor before making any investment decisions.
PlasmaTech Biopharmaceuticals, Inc (PTBIW) is a clinical-stage biotechnology company that develops and commercializes novel therapies for serious and life-threatening rare diseases. The company's pipeline includes gene therapy, cell therapy, and regenerative medicine products, targeting diseases such as diabetic foot ulcers, hemophilia, and lung cancer.